KK
DYN icon

KLP Kapitalforvaltning’s Dyne Therapeutics DYN Stock Holding History

KLP Kapitalforvaltning’s Portfolio DYN Stock Details DYN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$461K Hold
25,400
– – ﹤0.01% 1461
2025
Q4 		$497K Buy
25,400
+5,600
+28% +$106K ﹤0.01% 1420
2025
Q3 		$250K Buy
19,800
+4,600
+30% +$52.5K ﹤0.01% 1726
2025
Q2 		$145K Buy
15,200
+4,300
+39% +$47.3K ﹤0.01% 1901
2025
Q1 		$114K Hold
10,900
– – ﹤0.01% 1972
2024
Q4 		$257K Buy
+10,900
New +$322K ﹤0.01% 1713

Other funds holding DYN

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
FIS
FCPM III Services Naarden, Netherlands $722M AUM 73.61% 1-Year Est. Return

KLP Kapitalforvaltning's DYN Position: Q1 2026 in Review

KLP Kapitalforvaltning held its Dyne Therapeutics (DYN) position steady in Q1 2026 at 25,400 shares worth $461K. The position accounts for ﹤0.01% of the portfolio, ranked #1461.

KLP Kapitalforvaltning first reported a position in DYN in Q4 2024 and has held it in 6 quarters since. The position peaked at $497K in Q4 2025. 227 funds tracked by Wall St. Rank hold DYN as of Q1 2026.

  • KLP Kapitalforvaltning held 25,400 shares of Dyne Therapeutics worth $461K as of Q1 2026.
  • KLP Kapitalforvaltning left its Dyne Therapeutics share count unchanged in Q1 2026.
  • Dyne Therapeutics made up ﹤0.01% of KLP Kapitalforvaltning's portfolio in Q1 2026, its #1461 holding.
  • KLP Kapitalforvaltning first reported a position in Dyne Therapeutics in Q4 2024 and has held it in 6 quarters since.
  • KLP Kapitalforvaltning's Dyne Therapeutics position peaked at $497K in Q4 2025.
  • 227 funds tracked by Wall St. Rank held Dyne Therapeutics as of Q1 2026.

Based on KLP Kapitalforvaltning's 13F filing for Q1 2026, filed 29 Apr 2026.